Promethazine Hci Injection
Product Images NDC 51662-1248

5 FDA label images from Hf Acquisition Co. Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Promethazine Hci (NDC 51662-1248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co. Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ampule Label (1000510 0641 1496 31 Promethazine)

Ampule Label (1000510 0641 1496 31 Promethazine)
PROMETHAZINE HCI Injection, USP 50 mg/mL 1 mL Ampul label. The label includes warnings such as DEEP IM USE ONLY and PROTECT FROM LIGHT. It also displays the NDC 0641-1496-31 and shows the product is distributed by West-Ward. Additional numeric codes and lot/expiration placeholders are visible.*
FDA Label Image

Serialized Label (51662 1248 1 Promethazine 50 Serialized Label On Ampule)

Serialized Label (51662 1248 1 Promethazine 50 Serialized Label On Ampule)
PROMETHAZINE HCI 50 mg/mL injection in a single-dose amber glass ampule. The label indicates the product is distributed by HF Acquisition Co., LLC, Mukilteo, WA. The ampule is marked for prescription use only (Rx only).*
FDA Label Image

Boxed Warming (Boxed Warning)

Boxed Warming (Boxed Warning)
This image is a warnings text panel from the PROMETHAZINE HCI injection prescribing information. It highlights risks such as fatal respiratory depression in pediatric patients under 2 years, severe tissue injury including gangrene, and advises that the preferred administration route is deep intramuscular injection rather than intravenous or subcutaneous routes. It also references additional warnings and dosage administration notes.*
FDA Label Image
Logo (Logo)
PROMETHAZINE HCI 50 mg/mL injection vial packaging label. The label indicates it is for intramuscular and intravenous use and is manufactured by HF Acquisition Co. LLC, DBA HealthFirst. The vial is shown along with its secondary packaging, including a box with product and manufacturer details.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Promethazine HCl, depicting the molecular arrangement with a sulfur atom connecting two benzene rings and an N,N-dimethyl ethylamine side chain, along with the hydrochloride (HCl) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.